Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.
about
Cost of managing complications resulting from type 2 diabetes mellitus in CanadaAssessing response bias from missing quality of life data: the Heckman methodEconomic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollutionOutcomes research in the development and evaluation of practice guidelinesQuality of life after acute myocardial infarction: a comparison of diabetic versus non-diabetic acute myocardial infarction patients in Quebec acute care hospitalsIntervention with PTCA and CABG following thrombolysis for acute myocardial infarction. Australian data from GUSTO 1 (1991-3) and International Study Group r-TPA-Streptokinase Mortality (1989) trials. Global Utilisation of Streptokinase and Tissue.'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.The relationship between depressive symptoms, health service consumption, and prognosis after acute myocardial infarction: a prospective cohort study.Outcome and use of health services four years after admission for acute myocardial infarction: case record follow up studyA comparison of cardiovascular procedure use between the United States and Canada.Trends in hospital use for mechanical neck and back problems in Ontario and the United States: discretionary care in different health care systems.Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995.Acute myocardial infarction in Canada: improvement with time.Does aggressive care following acute myocardial infarction reduce mortality? Analysis with instrumental variables to compare effectiveness in Canadian and United States patient populationsMedical spending differences in the United States and Canada: the role of prices, procedures, and administrative expenses.Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction.Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patientsPractice patterns and trends in the use of medical therapy in patients undergoing percutaneous coronary intervention in Ontario.Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal populationHospital mortality of acute myocardial infarction in the thrombolytic era.Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.Utilisation of coronary angiography after acute myocardial infarction in Ontario over time: have referral patterns changed?Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British Cardiovascular Society Working Group.Do hospitals provide lower quality care on weekends?Quality of life in female myocardial infarction survivors: a comparative study with a randomly selected general female population cohort.Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER).Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.Rational use of medications: if Canada can't do it ...AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns.Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trialCost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-teTrends in PCI volume after negative results from the COURAGE trialControversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials.A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: a randomized trial in nonemergent patients.Practice variations, chance and quality of care.Benchmarking the provision of coronary artery surgery.Relative importance of improved hospital treatment and primary prevention. Results from 20 years of the Myocardial Infarction Register, Göteborg, Sweden.Survival after percutaneous endoscopic gastrostomy among older residents of Quebec.Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison.
P2860
Q24793101-12E55B39-3FD4-40D7-B113-0EDD63D87379Q24799249-956092C4-35A6-4E46-995D-0D1C9596821EQ24799588-FB2AA7C9-D029-44A9-9310-4DFBA9559DC3Q24806205-4B6694AE-30C8-44AE-AE5C-603C627FC31FQ25257680-0CC94FFC-EC32-4C2A-9F1B-C153FA5EE5C0Q31997518-69FF1F08-B882-4225-9B36-21575160159FQ33261643-728BA710-60FB-425B-8C0F-BCA0806158B1Q33372945-1D29E274-800E-4108-9C2C-6319E3D6B126Q33633433-63BF3C6B-7319-4DDA-8F64-F6D6A893DEF5Q33726389-93A90A0F-632E-428D-A0E5-7D282BB70D66Q34027145-0429AFD7-0CB3-4019-9C34-7078E1A722D2Q34038103-4D4A91A4-E5FD-424C-AA9C-32463AC22971Q34038131-ADB12F7F-DFCA-41BC-ABC5-1320FBB07E74Q34336091-553E6C45-384E-46F2-9C12-613670C4BB83Q34508457-AD3E9A00-6189-4A73-A671-D3C8EE07E6EDQ34599841-37283AB0-852E-4555-8DAC-AFB486D71B6CQ34983057-8C1228B0-E12D-41D9-8D5D-0CFF54363D05Q35026227-2CE18E4A-E63D-4F3B-ACEB-F8ABEB3E66F5Q35371457-2542BDF0-5AD0-4D4E-AAAD-54056AB72F65Q35371836-8524F311-9F72-4F1B-9F04-F6CF7EB9352DQ35419293-F049FDBA-42A2-44CC-8003-E9EE47E5A855Q35580556-75A154E1-8614-452D-8F1B-CC89DBD3AEF1Q35773438-F765BB4C-B3B4-4275-93EB-6DF5CA5493F9Q35955052-690C1EF1-0926-4D06-B117-A8FBD5F4FAD6Q36327825-CB620B79-AE78-4638-8F63-2A9D87C4EC3AQ36751838-EA565DEC-2161-41D6-B0F2-03F0A31A7F85Q37119085-36B9D0F0-B056-4F42-91E1-83CE1B42F5FAQ37246986-1FE312B7-AB81-4EA9-827F-93748433E2F2Q37361487-57F1D887-1B05-4EB5-AE69-F07F7C97ED51Q37521237-85D165E7-92ED-4798-B228-C7CCC95150B1Q37572029-C79CB811-5B90-4F67-B6BB-5A751AE569F4Q37580425-571C5705-D826-4489-90B6-59D754FC465BQ37682501-A1A54D25-A5A6-4B3F-BA07-5CE27C4776C9Q38630711-40474C03-2AB5-469F-9CB7-7C71F75BAAA0Q39291162-082AE8C8-B041-4D78-A912-48C064288438Q41826456-88ECAEFE-6F88-46B0-A3D1-F23D9DD49E79Q43010922-531E02B2-8CE7-4F87-904D-586F22F53162Q43758541-2623E0BC-2658-4CFF-AAA5-C52A18CFFE9BQ45305960-8458FFBC-37CB-492C-A069-6FB65F0AD710Q47630310-4550A617-E95B-4188-A62F-FF898F088191
P2860
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Use of medical resources and q ...... Canada and the United States.
@en
Use of medical resources and q ...... Canada and the United States.
@nl
type
label
Use of medical resources and q ...... Canada and the United States.
@en
Use of medical resources and q ...... Canada and the United States.
@nl
prefLabel
Use of medical resources and q ...... Canada and the United States.
@en
Use of medical resources and q ...... Canada and the United States.
@nl
P2093
P50
P921
P1476
Use of medical resources and q ...... Canada and the United States.
@en
P2093
Clapp-Channing NE
Granger CB
P304
P356
10.1056/NEJM199410273311706
P407
P577
1994-10-01T00:00:00Z